First Korean Three-Dose Intra-Articular Injection Registered in Brazil

Huons Group's Huons Meditech is pioneering new international markets with its osteoarthritis injectable products, following its success with aesthetic products.


On June 24, Huons Meditech Co., Ltd. announced that it had completed the registration of its sustained-release osteoarthritis injection, High Hyal Plus Inj, in Brazil through its local partner and has begun exports.

Huons Meditech Opens Export Route to Brazil for Osteoarthritis Injection 'High Hyal Plus' View original image

Interfarma, Huons Meditech's local partner in Brazil, was established in 1987 and is a professional consulting firm specializing in the import and export of pharmaceuticals and medical devices in Brazil, as well as in regulatory support.


High Hyal Plus by Huons Meditech is an arthritis treatment with high molecular weight, high-purity hyaluronic acid as its main ingredient. It is primarily used for patients with degenerative knee and shoulder arthritis. Among domestic products, it is the first osteoarthritis injection to be registered in Brazil for the three-dose regimen administered at weekly intervals.


Huons Meditech's High Hyal Plus is the only Korean-made, three-dose intra-articular injection that has received Class 4 medical device approval from ANVISA, the National Health Surveillance Agency under the Brazilian Ministry of Health. The company believes this will provide significant competitive advantage in the Brazilian market.


In Brazil, osteoarthritis affects 6 to 12 percent of the adult population, and more than one-third of those aged 65 and older, resulting in high demand for treatments. In particular, the intra-articular hyaluronic acid injection market for knee osteoarthritis (OA) is supported by a favorable structural foundation.



Kang Minjong, CEO of Huons Meditech, stated, "By entering the largest osteoarthritis injectable market in South America, which is Brazil, we have expanded our overseas sales channels. As Huons Meditech has once again demonstrated the quality and efficacy of its products beyond aesthetics through Brazil's stringent product approval process, we will further expand our reach in the global market."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing